Vine Health, the company behind a mobile app to support cancer patients, has partnered with Breast Cancer Haven to provide further resources and information to help cancer patients.
In April 2020 the company was announced as one of the winners of TechForce19, a fund to support the roll-out of tech during COVID-19, and last year was part of the DigitalHealth.London Accelerator programme.
Its mobile app supports cancer patients and their loved ones during treatment by allowing them to easily track and understand their care, including their symptoms, side effects, appointments and medications. By completing a 1-minute daily log, cancer patients can develop a clear overview of their progress through treatment and access advice on how to cope and when to access health services.
The new partnership means the Breast Cancer Haven’s resources and online support, from publications to self-help videos and online courses, will be available through the app. The charity was formed in 1997 to provide emotional support and information to help anyone diagnosed with the disease.
Vine Health will also be providing access to the charity’s Support Line through call, email or text, supporting all sarcoma patients.
The company said: “The Vinehealth app recognises the fundamental importance of a patient’s wellbeing and mental health, especially during the pandemic. Naturally, patients are more anxious due to self-isolation, changes in treatments and being considered high-risk with respect to COVID-19.”
“The platform enables those self-isolating to maintain a crucial link to their clinical team and to self-manage so that they feel more in control. Patients also have access to short courses, breathing & relaxation techniques– all to aid wellbeing and to improve the patient’s experience through their treatment journey and ultimately, outcomes from cancer.”
“This partnership with Breast Cancer Haven is a fundamental step towards further enriching the Vinehealth ecosystem and providing resources for as wide a range of patients as possible. As this continues to grow, so will the emphasis of changing the paradigm of cancer treatment and putting quality of life first.”
